about
Optimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular CarcinomaAn odorant-binding protein required for suppression of sweet taste by bitter chemicals.Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection?Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasisUpfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastasesTailored radiotherapeutic strategies for disseminated uterine cervical cancer patientsMulti-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients.Optimal Extent of Prophylactic Irradiation of Paraaortic Lymph Nodes in Patients with Uterine Cervical Cancer.Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors.Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer.The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma.The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma.Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer.Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner.Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients.Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy.Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.Optimal radiotherapy strategy for primary or recurrent fibromatosis and long-term results.The Ratio of Peripheral Regulatory T Cells to Lox-1 PMN-MDSC Predicts the Early Response to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer PatientsIntegration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancerDefining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineationThe Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with RadiotherapyCombining deep-inspiration breath hold and intensity-modulated radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma: Dosimetric evaluation using comprehensive plan quality indicesClinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology eraEffect of belly board with bladder compression device on small bowel displacement from the radiotherapy field for rectal cancerPredicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkersImproved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinomaMapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspectiveTreatment outcomes of radiotherapy for anaplastic thyroid cancerExtent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II gliomaTreatment outcomes based on radiation therapy fields for bifocal germinoma: Synchronous or disseminated disease?Treatment outcomes of radiotherapy for primary spinal cord gliomaClinical outcomes of radiotherapy for spinal cord ependymoma with adverse prognostic features: a single-center studyThe role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer
P50
Q26744097-DABE89D4-B8B1-4427-A9EA-4E6FB022A3D2Q30543677-52DB1244-0B38-42CF-A32C-CB0C4A33CF14Q34255467-D088E118-BFA2-41C6-B7AC-7B42FBECADCEQ35030263-89EAEC5D-3989-42AA-8B81-8A2FD8770EFAQ35206160-5EFD57C1-0878-4D35-B9C4-04D6C83E70E5Q35379790-03EC7F04-91B1-4266-A07F-54EF245C89D1Q35824260-A33F7B01-D0E8-46F6-AB04-68B1CA861F65Q35867392-439F0CBE-E977-49BA-A97A-BBD2E6D70556Q36106616-C587A7C3-6A9F-46F2-9F91-588624DB7A89Q36292688-A02D2F4C-4EA7-437C-B3CD-00347989C0E3Q36482535-F69E90A4-6B7A-4FFA-885C-F00DE3FB22A4Q36658459-F6BD588C-742C-465C-B6F9-530EB537B7E8Q37097507-07D27DED-ED30-4012-99D7-1DF824D525B4Q37297239-06DACA5F-F32E-4544-88FF-4EA4D1471F2FQ37641843-F9AC9441-4DD8-464C-A045-2E49B1174195Q38271767-0B18D410-F83C-43E9-B5A4-F37327C56726Q39659101-87F35EA5-E15D-450F-928C-0BD581221129Q40011137-532FEE14-BF0E-404C-8860-7E0E58D1C299Q42380314-B5B37DA2-2D20-4259-BF3E-524A9695A14DQ43865857-41D5F0C3-8CBD-46AF-A6F3-2F3E1B6314C8Q51746229-BBDA5479-AEFC-40B6-90EC-BB8C3DA576E7Q52150204-37F9BC61-DB20-47F5-81FC-773D82849BE5Q53225226-0E1FA839-0D35-46A9-86A5-6781C5872A6EQ55346932-B975FBEB-9001-4AA2-BCF3-4FBE81F82147Q58585965-040D6893-045A-4E7B-98DC-1473913B104FQ59115799-FE8E54A5-E0FE-468C-BF57-DC24D78BC435Q59115813-9E2E437F-571E-4E68-AFD6-B99839C89C24Q60920889-7012DD6C-E6B9-4010-8037-E94FDC3900A8Q64068363-D0F35EEA-E594-4743-9B01-F779082E0E7BQ64115476-340BA988-EEE2-4B4C-BA28-3673DDD45BD2Q86830343-5BD7E352-93E6-4393-BA3A-4B4070C12E5EQ87035599-DF57CE85-1DEA-4B14-8944-4DD5FD4C1FE9Q87837345-8C714624-8E96-4377-8246-A265BFD09F5FQ88076073-C5959AA5-5ED8-41AB-94F2-E8D85FE2CB03Q89459937-53A3EB89-B77C-43B0-949B-448D8773391DQ89602658-08B54C6F-C47C-4224-9BB6-8E651003257BQ90458253-C6E5C4AF-4B82-4920-ACDD-15910914683DQ91375599-B2D4D8CD-D0C2-410D-956B-4153AEF75527Q91375902-BECAB681-3C56-472A-A2F6-54152A7ACDB2Q91619779-F6728D8A-1B61-4D2F-90DB-E7F55B3F18FD
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2106-6856
@en
name
Hong In Yoon
@ast
Hong In Yoon
@en
Hong In Yoon
@nl
type
label
Hong In Yoon
@ast
Hong In Yoon
@en
Hong In Yoon
@nl
prefLabel
Hong In Yoon
@ast
Hong In Yoon
@en
Hong In Yoon
@nl
P106
P31
P496
0000-0002-2106-6856